Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PIK3CD | O00329 | 1/20 | 0.35 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.35 |
| ▸ | MTOR | P42345 | 1/20 | 0.35 |
| ▸ | ESR1 | P03372 | 8/20 | 0.35 |
| ▸ | ESR2 | Q92731 | 8/20 | 0.35 |
| ▸ | HSD17B1 | P14061 | 2/20 | 0.35 |
| ▸ | HSD17B2 | P37059 | 2/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.35 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.35 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.35 |
| ▸ | CYP2B6 | P20813 | 1/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.35 |
| ▸ | CYP1A1 | P04798 | 3/20 | 0.33 |
| ▸ | CYP1B1 | Q16678 | 2/20 | 0.33 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.33 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.33 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.33 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.33 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19296515 | 0.99 | ESR1 (0.37) | PIK3CDPIK3CAMTORESR1ESR2 | |
| SCHEMBL19296520 | 0.97 | PIK3CD (0.37) | PIK3CDPIK3CAMTORESR1ESR2 | |
| SCHEMBL19296548 | 0.96 | ESR1 (0.35) | PIK3CDPIK3CAMTORESR1ESR2 | |
| SCHEMBL19296535 | 0.96 | ESR1 (0.35) | PIK3CDPIK3CAMTORESR1ESR2 | |
| SCHEMBL19296517 | 0.95 | ESR1 (0.36) | PIK3CDPIK3CAMTORESR1ESR2 | |
| SCHEMBL19296525 | 0.95 | PIK3CD (0.35) | PIK3CDPIK3CAMTORESR1ESR2 | |
| SCHEMBL19296518 | 0.95 | PIK3CD (0.35) | PIK3CDPIK3CAMTORESR1ESR2 | |
| SCHEMBL23702372 | 0.95 | ESR1 (0.37) | ESR1ESR2HSD17B1HSD17B2CYP1A2 | |
| SCHEMBL19296431 | 0.95 | ESR1 (0.37) | ESR1ESR2HSD17B1HSD17B2CYP1A2 | |
| SCHEMBL19296505 | 0.95 | ESR1 (0.37) | ESR1ESR2HSD17B1HSD17B2CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10636976-B2 | Organic compound, light-emitting element, light-emitting device, electronic device, and lighting device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2020-04-28 | — | — | US | disclosed |
| US-20170250346-A1 | ORGANIC COMPOUND, LIGHT-EMITTING ELEMENT, LIGHT-EMITTING DEVICE, ELECTRONIC DEVICE, AND LIGHTING DEVICE | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2017-08-31 | — | — | US | disclosed |
| US-20170250346-A1 | ORGANIC COMPOUND, LIGHT-EMITTING ELEMENT, LIGHT-EMITTING DEVICE, ELECTRONIC DEVICE, AND LIGHTING DEVICE | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2017-08-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10636976-B2 | Organic compound, light-emitting element, light-emitting device, electronic device, and lighting device | TTI1, TTI2, TERF2 | PIK3CD 4002/4885PIK3CA 4296/4885MTOR 1291/4885 |
| US-20170250346-A1 | ORGANIC COMPOUND, LIGHT-EMITTING ELEMENT, LIGHT-EMITTING DEVICE, ELECTRONIC DEVICE, AND LIGHTING DEVICE | TTI1, TTI2, TERF2 | PIK3CD 4002/4885PIK3CA 4296/4885MTOR 1291/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.